Gene expression differences in skin fibroblasts in identical twins discordant for type 1 diabetes

Diabetes

Volumn 61, Issue 3, 2012, Pages 739-744

  Caramori, M Luiza ^a   Kim, Youngki ^b   Moore, Jason H ^c   Rich, Stephen S ^d   Mychaleckyj, Josyf C ^d   Kikyo, Nobuaki ^b   Mauer, Michael ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^c DARTMOUTH COLLEGE   (United States)

^d UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONIC ACID; COMPLEMENT; GLUCOSE; GLUTATHIONE; GLYCOSYLPHOSPHATIDYLINOSITOL ANCHORED PROTEIN; PROTEASOME; TRANSFORMING GROWTH FACTOR BETA;

ADULT; ARTICLE; CELL JUNCTION; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETIC PATIENT; EPIGENETICS; FEMALE; GENE EXPRESSION; GLUTATHIONE METABOLISM; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; INSULIN DEPENDENT DIABETES MELLITUS; INTRACELLULAR SIGNALING; MALE; MICROARRAY ANALYSIS; MONOZYGOTIC TWINS; PRIORITY JOURNAL; SKIN FIBROBLAST; TWIN DISCORDANCE;

ADULT; ARACHIDONIC ACID; CAPILLARY PERMEABILITY; CELLS, CULTURED; DIABETES MELLITUS, TYPE 1; DISEASES IN TWINS; FEMALE; FIBROBLASTS; GENE EXPRESSION PROFILING; GLUTATHIONE; HUMANS; MALE; MIDDLE AGED; SIGNAL TRANSDUCTION; SKIN; TRANSFORMING GROWTH FACTOR BETA; TWINS, MONOZYGOTIC;

EID: 84863135697     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db11-0617     Document Type: Article

References (54)

1. White NH, Sun W, Cleary PA, et al. Prolonged effect of intensive therapy on the risk of retinopathy complications in patients with type 1 diabetes mellitus: 10 years after the Diabetes Control and Complications Trial. Arch Ophthalmol 2008;126:1707-1715
2. Fioretto P, Mauer SM, Bilous RW, Goetz FC, Sutherland DER, Steffes MW. Effects of pancreas transplantation on glomerular structure in insulin-dependent diabetic patients with their own kidneys. Lancet 1993;342:1193-1196 (Pubitemid 23331708)
3. Fioretto P, Steffes MW, Sutherland DER, Goetz FC, Mauer M. Reversal of lesions of diabetic nephropathy after pancreas transplantation. N Engl J Med 1998;339:69-75 (Pubitemid 28304880)
4. Chernov AV, Baranovskaya S, Golubkov VS, et al. Microarray-based transcriptional and epigenetic profiling of matrix metalloproteinases, collagens, and related genes in cancer. J Biol Chem 2010;285:19647-19659
5. Roy S, Sala R, Cagliero E, Lorenzi M. Overexpression of fibronectin induced by diabetes or high glucose: phenomenon with a memory. Proc Natl Acad Sci USA 1990;87:404-408
6. Villeneuve LM, Natarajan R. The role of epigenetics in the pathology of diabetic complications. Am J Physiol Renal Physiol 2010;299:F14-F25
7. Sun G, Reddy MA, Yuan H, Lanting L, Kato M, Natarajan R. Epigenetic histone methylation modulates fibrotic gene expression. J Am Soc Nephrol 2010;21:2069-2080
8. El-Osta A, Brasacchio D, Yao D, et al. Transient high glucose causes persistent epigenetic changes and altered gene expression during subsequent normoglycemia. J Exp Med 2008;205:2409-2417
9. Miao F, Smith DD, Zhang L, Min A, Feng W, Natarajan R. Lymphocytes from patients with type 1 diabetes display a distinct profile of chromatin histone H3 lysine 9 dimethylation: an epigenetic study in diabetes. Diabetes 2008;57:3189-3198
10. Bell JT, Spector TD. A twin approach to unraveling epigenetics. Trends Genet 2011;27:116-125
11. Kaelber DC, Pickett F. Simple table to identify children and adolescents needing further evaluation of blood pressure. Pediatrics 2009;123:e972-e974
12. Huang C, Kim Y, Caramori MLA, et al. Cellular basis of diabetic nephropathy II: the TGF β-system and diabetic nephropathy lesions in type 1 diabetes. Diabetes 2002;51:3577-3581 (Pubitemid 35403466)
13. Huang C, Kim Y, Caramori ML, et al. Cellular basis of diabetic nephropathy: III. In vitro GLUT1 mRNA expression and risk of diabetic nephropathy in type 1 diabetic patients. Diabetologia 2004;47:1789-1794 (Pubitemid 40022415)
14. Caramori ML, Kim Y, Fioretto P, et al. Cellular basis of diabetic nephropathy: IV. Antioxidant enzyme mRNA expression levels in skin fibroblasts of type 1 diabetic sibling pairs. Nephrol Dial Transplant 2006;21:3122-3126 (Pubitemid 44567083)
15. Huang C, Kim Y, Caramori ML, et al. Diabetic nephropathy is associated with gene expression levels of oxidative phosphorylation and related pathways. Diabetes 2006;55:1826-1831 (Pubitemid 44324139)
16. Reif DM, Dudek SM, Shaffer CM, Wang J, Moore JH. Exploratory visual analysis of pharmacogenomic results. Pac Symp Biocomput 2005;10:296-307
17. Reif DM, Moore JH. Visual analysis of statistical results from microarray studies of human breast cancer. Oncol Rep 2006;15(Spec no):1043-1047
18. Beyan H, Drexhage RC, van der Heul Nieuwenhuijsen L, et al. Monocyte gene-expression profiles associated with childhood-onset type 1 diabetes and disease risk: a study of identical twins. Diabetes 2010;59:1751-1755
19. Wilson SB, Kent SC, Horton HF, et al. Multiple differences in gene expression in regulatory Valpha 24Jalpha Q T cells from identical twins discordant for type I diabetes. Proc Natl Acad Sci USA 2000;97:7411-7416 (Pubitemid 30431477)
20. Ayilavarapu S, Kantarci A, Fredman G, et al. Diabetes-induced oxidative stress is mediated by Ca2+-independent phospholipase A2 in neutrophils. J Immunol 2010;184:1507-1515
21. Reddy MA, Adler SG, Kim Y-S, et al. Interaction of MAPK and 12-lipoxygenase pathways in growth and matrix protein expression in rat mesangial cells. Am J Physiol Renal Physiol 2002;283:F985-F994 (Pubitemid 35192465)
22. Kang S-W, Natarajan R, Shahed A, et al. Role of 12-lipoxygenase in the stimulation of p38 mitogen-activated protein kinase and collagen α5(IV) in experimental diabetic nephropathy and in glucose-stimulated podocytes. J Am Soc Nephrol 2003;14:3178-3187 (Pubitemid 37509293)
23. Liu Y, Freedman BI, Burdon KP, et al. Association of arachidonate 12-lipoxygenase genotype variation and glycemic control with albuminuria in type 2 diabetes. Am J Kidney Dis 2008;52:242-250 (Pubitemid 351978132)
24. Ziyadeh FN. Different roles for TGF-β and VEGF in the pathogenesis of the cardinal features of diabetic nephropathy. Diabetes Res Clin Pract 2008;82(Suppl. 1):S38-S41
25. Sharma K, Ziyadeh FN. Hyperglycemia and diabetic kidney disease. The case for transforming growth factor-β as a key mediator. Diabetes 1995;44:1139-1146
26. Dave GS, Kalia K. Hyperglycemia induced oxidative stress in type-1 and type-2 diabetic patients with and without nephropathy. Cell Mol Biol (Noisy-le-grand) 2007;53:68-78 (Pubitemid 350164307)
27. Yildirim Z, Uçgun NI, Kiliç N, Gürsel E, Sepici-Dinçel A. Antioxidant enzymes and diabetic retinopathy. Ann N Y Acad Sci 2007;1100:199-206 (Pubitemid 47092653)
28. Ceriello A, Morocutti A, Mercuri F, et al. Defective intracellular antioxidant enzyme production in type 1 diabetic patients with nephropathy. Diabetes 2000;49:2170-2177
29. Hodgkinson AD, Bartlett T, Oates PJ, Millward BA, Demaine AG. The response of antioxidant genes to hyperglycemia is abnormal in patients with type 1 diabetes and diabetic nephropathy. Diabetes 2003;52:846-851 (Pubitemid 36323595)
30. Zhang J, Gerhardinger C, Lorenzi M. Early complement activation and decreased levels of glycosylphosphatidylinositol-anchored complement inhibitors in human and experimental diabetic retinopathy. Diabetes 2002;51:3499-3504 (Pubitemid 35403456)
31. Gerl VB, Bohl J, Pitz S, Stoffelns B, Pfeiffer N, Bhakdi S. Extensive deposits of complement C3d and C5b-9 in the choriocapillaris of eyes of patients with diabetic retinopathy. Invest Ophthalmol Vis Sci 2002;43:1104-1108 (Pubitemid 34258279)
32. Rosoklija GB, Dwork AJ, Younger DS, Karlikaya G, Latov N, Hays AP. Local activation of the complement system in endoneurial microvessels of diabetic neuropathy. Acta Neuropathol 2000;99:55-62 (Pubitemid 30093439)
33. Falk RJ, Dalmasso AP, Kim Y, et al. Neoantigen of the polymerized ninth component of complement. Characterization of a monoclonal antibody and immunohistochemical localization in renal disease. J Clin Invest 1983;72:560-573 (Pubitemid 13051316)
34. Hovind P, Hansen TK, Tarnow L, et al. Mannose-binding lectin as a predictor of microalbuminuria in type 1 diabetes: an inception cohort study. Diabetes 2005;54:1523-1527 (Pubitemid 40586685)
35. Hansen TK, Tarnow L, Thiel S, et al. Association between mannose-binding lectin and vascular complications in type 1 diabetes. Diabetes 2004;53:1570-1576 (Pubitemid 38697671)
36. Østergaard J, Hansen TK, Thiel S, Flyvbjerg A. Complement activation and diabetic vascular complications. Clin Chim Acta 2005;361:10-19 (Pubitemid 41382606)
37. Nørgaard K, Jensen T, Feldt-Rasmussen B. Transcapillary escape rate of albumin in hypertensive patients with type 1 (insulin-dependent) diabetes mellitus. Diabetologia 1993;36:57-61 (Pubitemid 23018336)
38. Chagnac A, Korzets A, Zevin D, et al. Effect of enalapril on the microvascular albumin leakage in patients with diabetic microangiopathy and normal or mildly elevated blood pressure. Clin Nephrol 1994;41:144-149 (Pubitemid 24085377)
39. Dejana E, Orsenigo F, Lampugnani MG. The role of adherens junctions and VE-cadherin in the control of vascular permeability. J Cell Sci 2008;121:2115-2122
40. Lee H-Z, Yeh F-T, Wu C-H. The effect of elevated extracellular glucose on adherens junction proteins in cultured rat heart endothelial cells. Life Sci 2004;74:2085-2096 (Pubitemid 38210435)
41. Davidson MK, Russ PK, Glick GG, Hoffman LH, Chang MS, Haselton FR. Reduced expression of the adherens junction protein cadherin-5 in a diabetic retina. Am J Ophthalmol 2000;129:267-269 (Pubitemid 30089297)
42. Rudini N, Felici A, Giampietro C, et al. VE-cadherin is a critical endothelial regulator of TGF-β signalling. EMBO J 2008;27:993-1004 (Pubitemid 351508155)
43. Alvarez-Muñoz P, Mauer M, Kim Y, et al. Cellular basis of diabetic nephropathy: V. Endoglin expression levels and diabetic nephropathy risk in patients with type 1 diabetes. J Diabetes Complications 2010;24:242-249
44. Lorenz M, Wilck N, Meiners S, et al. Proteasome inhibition prevents experimentally induced endothelial dysfunction. Life Sci 2009;84:929-934
45. Luo ZF, Qi W, Feng B, et al. Prevention of diabetic nephropathy in rats through enhanced renal antioxidative capacity by inhibition of the proteasome. Life Sci 2011;88:512-520
46. Zhong Q, Kowluru RA. Role of histone acetylation in the development of diabetic retinopathy and the metabolic memory phenomenon. J Cell Biochem 2010;110:1306-1313
47. Yu XY, Geng YJ, Liang JL, et al. High levels of glucose induce apoptosis in cardiomyocyte via epigenetic regulation of the insulin-like growth factor receptor. Exp Cell Res 2010;316:2903-2909
48. Seaquist ER, Goetz FC, Rich S, Barbosa J. Familial clustering of diabetic kidney disease. Evidence for genetic susceptibility to diabetic nephropathy. N Engl J Med 1989;320:1161-1165 (Pubitemid 19124296)
49. Borch-Johnsen K, Nørgaard K, Hommel E, et al. Is diabetic nephropathy an inherited complication? Kidney Int 1992;41:719-722
50. Quinn M, Angelico MC, Warram JH, Krolewski AS. Familial factors determine the development of diabetic nephropathy in patients with IDDM. Diabetologia 1996;39:940-945 (Pubitemid 26249113)
51. Freedman BI, Tuttle AB, Spray BJ. Familial predisposition to nephropathy in African-Americans with non-insulin-dependent diabetes mellitus. Am J Kidney Dis 1995;25:710-713
52. Faronato PP, Maioli M, Tonolo G, et al.; The Italian NIDDM Nephropathy Study Group. Clustering of albumin excretion rate abnormalities in Caucasian patients with NIDDM. Diabetologia 1997;40:816-823 (Pubitemid 27306960)
53. Canani LH, Gerchman F, Gross JL. Familial clustering of diabetic nephropathy in Brazilian type 2 diabetic patients. Diabetes 1999;48:909-913 (Pubitemid 29153094)
54. Fava S, Azzopardi J, Hattersley AT, Watkins PJ. Increased prevalence of proteinuria in diabetic sibs of proteinuric type 2 diabetic subjects. Am J Kidney Dis 2000;35:708-712 (Pubitemid 30185517)